CN Patent

CN1271276A — 经舌下或含服给药的控释药物

Assigned to Pentech Pharmaceuticals Inc · Expires 2000-10-25 · 26y expired

What this patent protects

一种用于经舌下或含服途径给药的组合物,该组合物可使水溶性药物如阿扑吗啡比较缓慢地释放。

USPTO Abstract

一种用于经舌下或含服途径给药的组合物,该组合物可使水溶性药物如阿扑吗啡比较缓慢地释放。

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN1271276A
Jurisdiction: CN
Classification: —
Expires: 2000-10-25
Drug substance claim: No
Drug product claim: No
Assignee: Pentech Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.